Inventor · disambiguated record
David Michel Adrien Taddei
Also filed as: TADDEI DAVID MICHEL ADRIEN
14 granted patents·2 pending applications·171 citations·filing 2009–2020
90Inventor score
Files withCELLCENTRIC LTD6RESPIVERT LTD5ITO KAZUHIRO3CORCORAN JONATHAN PATRICK THOMAS1KING S COLLEGE LONDON1
Top patents by PatentIndex Score
16 records- 0196US8293748B2p38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2009·Granted Oct 23, 2012·47 cites·19 claims
- 0295US8618140B2P38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2012·Granted Dec 31, 2013·41 cites·20 claims
- 0395US8299073B2P38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2009·Granted Oct 30, 2012·50 cites·19 claims
- 0494US8975285B2P38 MAP kinase inhibitorsRESPIVERT LTD·Filed 2013·Granted Mar 10, 2015·26 cites·3 claims
- 0587US9227977B2Phosphoinositide 3-kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Jan 5, 2016·4 cites·7 claims
- 0674US10118920B2Isoxazolyl substituted benzimidazolesCELLCENTRIC LTD·Filed 2016·Granted Nov 6, 2018·2 cites·16 claims
- 0770US9447028B2Therapeutic aryl-amido-aryl compounds and their useKING S COLLEGE LONDON·Filed 2015·Granted Sep 20, 2016·1 cites·20 claims
- 0860US11377443B2Pharmaceutical compoundsCELLCENTRIC LTD·Filed 2020·Granted Jul 5, 2022·0 cites·8 claims
- 0960US9556184B2Phosphoinositide 3-kinase inhibitorsRESPIVERT LTD·Filed 2015·Granted Jan 31, 2017·0 cites·3 claims
- 1058US9745306B22-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-(trifluoromethyl)benzyl) quinazolin-4(3H)-one derivatives and their use as phosphoinositide 3-kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Aug 29, 2017·0 cites·15 claims
- 1156US10696666B2Pharmaceutical compoundsCELLCENTRIC LTD·Filed 2017·Granted Jun 30, 2020·0 cites·8 claims
- 1247US2017334919A12-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1 -yl)methyl)-3-(2-(trifluoro-met hyl)benzyl)quinazolin-4(3h)-one derivatives and their use as phosphoinositide 3-kinase inhibitorsRESPIVERT LTD·Filed 2017·Application pending·0 cites
- 1343US11453662B2Process for preparing modulators of p300 and/or CBPCELLCENTRIC LTD·Filed 2019·Granted Sep 27, 2022·0 cites·15 claims
- 1442US10647704B2Pharmaceutical compoundsCELLCENTRIC LTD·Filed 2017·Granted May 12, 2020·0 cites·8 claims
- 1542US2012149737A1Therapeutic Aryl-Amido-Aryl Compounds and Their UseCORCORAN JONATHAN PATRICK THOMAS·Filed 2010·Application pending·0 cites
- 1639US10428065B2Isoxazolyl substituted imidazopyridinesCELLCENTRIC LTD·Filed 2016·Granted Oct 1, 2019·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when David Michel Adrien Taddei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →